Other

Dataset Information

0

CITE-seq of CAR-NK cells


ABSTRACT: Primary chimeric antigen receptor (CAR) natural killer (NK) cells show strong cytotoxic efficacy against acute myeloid leukemia (AML) in vivo. However, NK cell-mediated tumor killing is often impaired by tumor-mediated immune cell inactivation. Here, we report a novel strategy to overcome NK cell inhibition caused by the immune checkpoint NKG2A, which interacts with HLA-E expressed on AML blasts. We generated AML-specific CD33-directed CAR (CAR33)-KLRC1ko-NK cells with CRISPR/Cas9-based gene editing of the NKG2A-encoding KLRC1 gene. Single-cell multi-omic analyses revealed a higher proportion of activated cells in CAR33-NK- and CAR33-KLRC1ko-NK pools, which were preserved following AML-cell contact. This activated state of the CAR33-KLRC1ko-NK cells has been translated into improved antileukemic activity in vitro and in vivo against AML cell lines and primary blasts. This dual modification of primary NK cells has the potential to bypass the suppressive effect not only of AML but also in a broad range of other cancer identities.

ORGANISM(S): Homo sapiens

PROVIDER: GSE221552 | GEO | 2024/07/16

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-09-01 | GSE178566 | GEO
2015-11-07 | E-GEOD-74780 | biostudies-arrayexpress
2022-09-20 | E-MTAB-12228 | biostudies-arrayexpress
2015-11-07 | GSE74780 | GEO
2015-07-24 | E-GEOD-50928 | biostudies-arrayexpress
2015-07-24 | E-GEOD-34885 | biostudies-arrayexpress
2024-10-11 | GSE191074 | GEO
2022-09-26 | GSE214042 | GEO
2021-10-26 | GSE186115 | GEO
2024-04-26 | GSE263399 | GEO